NHS Industries Common Shares to Begin Trading on the Canadian Securities Exchange Effective April 5, 2018 under the Symbol “NHS”

Posted on

April 4, 2018 - Vancouver, BC

NHS Industries Ltd. (www.nhsindustries.ca) (“NHS” or the “Company”) is pleased to announce that its final prospectus was accepted by the British Columbia Securities Commission in February 2018 and that the Canadian Securities Exchange (the “CSE” or the “Exchange”) has accepted the Company’s common shares for trading on the Exchange. The Company’s shares will begin trading on the Exchange as of the opening of trading on Thursday, April 5, 2018 under the symbol “NHS”. The Company is also pleased to provide an update regarding the results of the Company’s Annual General and Special Meeting held on March 29, 2018.

The Meeting

An annual general and special meeting (the “Meeting”) of the shareholders of NHS was held on Thursday, March 29, 2018. Meeting materials containing full details were mailed to those shareholders who held shares as of February 8, 2018. Meeting materials are available on SEDAR. At the Meeting shareholders elected Carman Parente, Anthony Chan, C. Lorraine Pike and David A. Johnson as directors; appointed Adam Sung Kim Ltd. as auditors; approved and ratified the Company’s stock option plan and ratified the Advance Notice Policy. Following the Meeting, the Board of Directors appointed Carman Parente as President and Chief Executive Officer and appointed Anthony Chan as Chief Financial Officer.

Advance Notice Policy

The Board of Directors of the Company approved an Advance Notice Policy which was ratified by the shareholders of the Company at the Company's shareholder meeting held on March 29, 2018. The Advance Notice Policy includes, among other things, a provision that requires advance notice be given to the Company in circumstances where nominations of persons for election to the Board are made by shareholders of the Company, other than pursuant to (i) a requisition of meeting or (ii) a shareholder proposal made pursuant to the provisions of the Business Corporations Act (British Columbia), in order for any director nominee to be eligible for election at any annual or special meeting of shareholders of the Company. Additionally, the Advance Notice Policy sets a deadline by which holders of common shares of the Company must submit director nominations to the Company prior to any annual or special meeting of shareholders, sets forth the information that a shareholder must include in the notice to the Company, and establishes the form in which the shareholder must submit the notice for that notice to be in proper written form.

In the case of an annual meeting of shareholders, notice to the Company must be made not less than 30 days and not more than 65 days prior to the date of the annual meeting. However, in the event that the annual meeting is to be held on a date that is less than 50 days after the date on which the first public announcement of the date of the annual meeting was made, notice may be made not later than the close of business on the tenth day following such public announcement.

In the case of a special meeting of shareholders (which is not also an annual meeting) notice to the Company must be made not later than the close of business on the fifteenth (15th) day following the day on which the first public announcement of the date of the special meeting was made.

The full text of the Advance Notice Policy is available under the Company's profile on SEDAR at www.sedar.com.

About NHS

NHS owns 5.5 acres of prime agricultural land in Langley, BC that includes over 48,000 square feet of greenhouse capacity and 80,000 cubic yards of saleable peat soil. The Langley Agri-campus was recently spun out from its former parent – New Age Farm Inc. NHS Industries Ltd. is an agriservices company aimed at providing turnkey services to makers, bakers and growers. NHS is in the process of building out a commercial commissary kitchen that will be available to on site growers as well as local makers, bakers and growers producing small batch artisanal food products. NHS is also exploring various other avenues for businesses that can operate at the Langley Agri-campus including the potential for operations related legalized marijuana. For further information about NHS, please consult the Company’s profile on SEDAR at www.sedar.com.

###

On Behalf of the Board of Directors

Carman Parente

President and Chief Executive Officer

info@nhsindustries.ca

(888) 202-5153

 

WWW.NHSINDUSTRIES.CA



This news release contains forward-looking statements, which relate to future events or future performance and reflect management’s current expectations and assumptions. Such forward-looking statements reflect management’s current beliefs and are based on assumptions made by and information currently available to the Company. Readers are cautioned that these forward looking statements are neither promises nor guarantees, and are subject to risks and uncertainties that may cause future results to differ materially from those expected including, but not limited to completion of planned improvements at the Langley property, the completion of the listing of the Company’s common shares on the CSE, the availability of financing needed to complete the Company’s planned improvements on commercially reasonable terms, planned occupancy by tenants, commencement of operations, the ability to mitigate the risk of loss through appropriate insurance. These forward-looking statements are made as of the date hereof and the Company does not assume any obligation to update or revise them to reflect new events or circumstances save as required under applicable securities legislation. This news release does not constitute an offer to sell securities and the Company is not soliciting an offer to buy securities in any jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such jurisdiction. 

This news release does not constitute an offer of securities for sale in the United States. These securities have not and will not be registered under United States Securities Act of 1933, as amended, or any state securities laws and may not be offered or sold in the United States or to a U.S. Person unless so registered, or an exemption from registration is relied upon.

The Canadian Securities Exchange has neither approved nor disapproved the contents of this news release and accepts no responsibility for the adequacy or accuracy hereof.

Newer Post →